Find News

Filter articles

Showing 91 to 100 of 3777 results

USPTO unveils tool to access key FDA data

US06-09-2022Staff Writer

Web page reveals information concerning patent term extension applications | President Joe Biden urged collaboration between USPTO and FDA.

Big pharma firm hits back in COVID-19 tech dispute

Germany, UK06-09-2022Staff Writer

CureVac accuses Pfizer and its German partner of infringing patented tech in landmark COVID-19 treatment | The pharma giant says that the patents are invalid

Novo Nordisk makes $1.1bn bid for biopharma company

Denmark, US02-09-2022Staff Writer

Massachusetts-based target company specialises in rare blood disorders | Deal gives Novo Nordisk access to lead development candidate, etavopivat.

Court delivers split ruling in lung drug dispute

US01-09-2022Muireann Bolger

Lengthy opinion invalidated plaintiff’s patent but ruled that defendant’s would still infringe | Patents at issue related to treatment for high blood pressure in the lungs.

Carpmaels & Ransford adds partner with UPC focus

EU01-09-2022Sarah Speight

New partner brings pharma and chemistry focus, and boosts the European firm’s Unified Patent Court team.

AltaThera hits competitor with trade secret suit

US01-09-2022Staff Writer

Suit claims a contractor used AltaThera secrets to launch a rival heart arrhythmia drug | Chicago-based company wants the court to add its founder as co-inventor on patent.

O’Melveny recruits IP litigator for New York office

US30-08-2022Muireann Bolger

O’Melveny has hired life sciences patent litigator Gregory Morris for its New York office as a partner in its IP and technology practice group.

Novartis sued over blockbuster heart failure drug

US30-08-2022Muireann Bolger

Pharma company facing lawsuit from two universities | Dispute centres on therapeutically effective co-crystals patent.

Moderna hits Pfizer and BioNTech with COVID-19 vaccine patent suit

US30-08-2022Staff Writer

Moderna has taken Pfizer and its German partner BioNTech to court, alleging that the pair copied Moderna’s technology when developing their COVID-19 vaccine.

GSK presses court to deny Teva’s ‘skinny label’ petition

US25-08-2022Sarah Speight

Teva’s petition relies on a “blatantly misleading” question, argues GSK | Case presents “no new issues” that haven’t already been decided.

Showing 91 to 100 of 3777 results